Protara Therapeutics's total assets for Q2 2025 were $156.93M, a decrease of -6.90% from the previous quarter. TARA total liabilities were $12.51M for the fiscal quarter, a 24.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.